The role of T cells in primary biliary cirrhosis

Seminars in Liver Disease

Volumn 17, Issue 2, 1997, Pages 105-113

  Van De Water, Judy ^a   Shimoda, Shinji ^a   Niho, Yoshiyuki ^b   Coppel, Ross ^c   Ansari, Aftab ^d   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KYUSHU UNIVERSITY   (Japan)

^c MONASH UNIVERSITY   (Australia)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Liver; Primary biliary cirrhosis; Pyruvate dehydrogenase; T cells; T cell receptor

Indexed keywords

AMINO ACID; AUTOANTIBODY; AUTOANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; GLYCOGEN PHOSPHORYLASE B; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; INSULIN; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE; PYRUVATE DEHYDROGENASE COMPLEX; T LYMPHOCYTE RECEPTOR; THIOCTIC ACID;

ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CROSS REACTION; GENE REARRANGEMENT; HUMAN; LIVER BIOPSY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0030900830     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007188     Document Type: Article

References (60)

1. Kaplan MM: Primary biliary cirrhosis [review]. N England J Med 316:521-8, 1987.
2. Ahrens E Jr, Payne MA, Kunkel HG, et al. Primary biliary cirrhosis: 1950 [classic article]. Medicine 73:264-78, 1994.
3. Walker JG, Doniach D, Roitt IM, Sherlock S: Serological tests in the diagnosis of primary biliary cirrhosis. Lancet 1:827-30, 1965.
4. Van de Water J, Gershwin ME, Leung P, et al: The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 167:1791-9, 1988.
5. Fussey SP, Guest JR, James OF, et al: Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 85:8654-8, 1988.
6. Hoffmann RM, Pape GR, Spengler U, et al: Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosis. Clin Exp Immunol 76:210-5, 1989.
7. Bjorkland A, Festin R, Mendel-Hartvig I, et al: Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and natural killer cells and recruitment of primed memory T cells. Hepatology 13:1106-11, 1991.
8. Leon MP, Spickett G, Jones DE, Bassendine MF: DC4+T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clin Exp Immunol 99:233-9, 1995.
9. Lohr HF, Schlaak JF, Gerken G. et al: Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 14:161-6, 1994.
10. Nakanuma Y, Kono N: Expression of HLA-DR antigens on interlobular bile ducts in primary biliary cirrhosis and other hepatobiliary diseases: an immunohistochemical study. Hum Pathol 22:431-6, 1991.
11. Lohr H, Fleischer B, Gerken O, et al: Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehydrogenase complex. J Hepatol 18:322-7, 1993.
12. Meuer SC, Moebius U, Manns MM, et al: Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis. Eur J Immunol 18: 1447-52, 1988.
13. Si L, Whiteside TL, Schade RR, et al: T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls. J Clin Immunol 4:262-72, 1984.
14. Van de Water J, Ansari AA, Surh CD, et al: Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis J Immunol 146:89-94, 1991.
15. Meuer SC, Moebius U, Manns MM, et al: Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis. Eur J Immunol 18: 1447-52, 1988.
16. Van de Water J, Ansari AA, Surh CD, et al: Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 146:89-94, 1991.
17. Surh CD, Ahmed-Ansari A, Gershwin ME: Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis. J Immunol 144:2647-52, 1990.
18. Surh CD, Coppel R, Gershwin ME: Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis: implication for a conformational autoepitope. J Immunol 144:3367-74, 1990.
19. Van de Water J, Ansari A, Prindiville T, et al: Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 181:723-33, 1995.
20. Palmer JM, Bassendine MF, James OF, Yeaman SJ: Human pyruvate dehydrogenase complex as an autoantigen in primary biliary cirrhosis. Clin Sci 85:289-93, 1993.
21. Gershwin ME, Rowley M, Davis PA, et al: Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies. Prog Liver Dis 10:47-61, 1992.
22. Van de Water J, Turchany J, Leung PS, et al: Molecular mimicry in primary biliary cirrhosis: evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest 91:2653-64, 1993.
23. Shimoda S, Nakamura M, Ishibashi H, et al: HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 181:1835-45, 1995.
24. Butler P, Hamilton-Miller J, Baum H, Burroughs AK: Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens: evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis? Biochem Mol Biol Int 35:473-85, 1995.
25. Yeaman SJ, Fussey SP, Danner DJ, et al: Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1:1067-70, 1988.
26. Fussey SP, Ali ST, Guest JR, et al: Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci USA 87:3987-91, 1990.
27. Teoh KL, Mackay IR, Rowley MJ, Fussey SP: Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry. Hepatology 19:1029-33, 1994.
28. Burroughs AK, Butler P, Sternberg MJ, Baum H: Molecular mimicry in liver disease. Nature 358:377-8, 1992.
29. Joplin R, Lindsay JG, Hubscher SG, et al: Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study. Hepatology 14:442-7, 1991.
30. Fujinami RS, Oldstone MBA: Amino acid homology and cross-reacting immune responses between the encephalitogenic site of myelin basic protein and virus: virus-induced autoimmunity. In: Vaccine 86: Modern Approaches to Immunizations. New York: Cold Spring Harbor Laboratory, 1986, pp 247-51.
31. Oldstone MB: Molecular mimicry and autoimmune disease [published erratum appears in Cell 51:878, 1987.]. Cell 50: 819-20, 1987.
32. Lehmann PV, Forsthuber T, Miller A, Sercarz EE: Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155-7, 1992.
33. Gautam AM, Lock CB, Smilek DE, et al: Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity. Proc Natl Acad Sci USA 91:767-71, 1994.
34. Nickowitz RE, Worman HJ: Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210. J Exp Med 178:2237-42, 1993.
35. Luo AM, Garza KM, Hunt D, Tung KS: Antigen mimicry in autoimmune disease sharing of amino acid residues critical for pathogenic T cell activation. J Clin Invest 92:2117-23, 1993.
36. Matsui M, Nakamura M, Ishibashi H, et al: Human monoclonal antibodies from a patient with primary biliary cirrhosis that recognize two distinct autoepitopes in the E2 component of the pyruvate dehydrogenase complex. Hepatology 18:1069-77, 1993.
37. Graham S, Wang ECY, Jenkins O, Borysiewicz LK: Analysis of the human T-cell response to picornaviruses: Identification of T-cell epitopes close to B cells epitopes in poliovirus. J Virol 67:1627-37, 1993.
38. Sercarz EE, Lehmann PV, Ametani A, et al: Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 11:729-66, 1993.
39. Moudgil KD, Sercarz EE: The T cell repertoire against cryptic self determinants and its involvement in autoimmunity and cancer. Clin Immunol Immunopathol 73:283-9, 1994.
40. Harris DP, Vordermeier HM, Singh M, et al: Cross-recognition by T cells of an epitope shared by two unrelated mycobacterial antigens. Eur J Immunol 25:3173-9, 1995.
41. Jorgensen JL, Reay PA, Ehrich EW, Davis MM: Molecular components of T-cell recognition. Annu Rev Immunol 10: 835-73, 1992.
42. Kropshofer H, Max H, Muller CA, et al: Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif. J Exp Med 175:1799-803, 1992.
43. Hammer J, Valsasnini P, Tolba K, et al: Promiscuous and allelespecific anchors in HL-DR-binding peptides. Cell 74:197-203, 1993.
44. Stern LJ, Brown JH, Jardetzky TS, et al: Crystal structure of the human class II MHC protein HL-DR1 complexed with an influenza virus peptide. Nature 368:215-21, 1994.
45. Matsushita S, Takahashi K, Motoki M, et al: Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med 180:873-83, 1994
46. Wucherpfennig KW, Sette A, Southwood S, et al: Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 179:279-90, 1994.
47. Ercilla G, Pares A, Arriaga F, et al: Primary biliary cirrhosis associated with HLA-DRw3. Tissue Antigens 14:449-52, 1979.
48. Prochazka EJ, Terasaki PI, Park MS, et al: Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 322:1842-4, 1990.
49. Johnston DE, Kaplan MM, Miller KB, et al: Histocompatibility antigens in primary biliary cirrhosis. Am J Gastroenterol 82: 1127-9, 1987.
50. Miyamori H, Kato Y, Kobayashi K, Hattori N: HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion 26:213-7, 1983.
51. Seki T, Kiyosawa K, Ota M, et al: Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients. Hepatology 18:73-8, 1993.
52. Bassendine MF, Dewar PJ, James OF: HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut 26:625-8, 1985.
53. Shimoda S, Nakamura M, Ishibashi H, et al: HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 181:1835-45, 1995.
54. Imanishi T, Akaza T, Kimura A, et al: Allele and halpotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuiji K, Aizawa M, Sasazuki T (eds): HLA 1991. Oxford, England: Oxford University Press, pp 1065-1220, 1991.
55. Meinl E, Weber F, Drexler K, et al: Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. J Clin Invest 92:2633-43, 1993.
56. Moebius U, Manns M, Hess G, et al: T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones. Eur J Immunol 20: 889-96, 1990.
57. Tsai SL, Lai MY, Chen DS: Analysis of rearranged T cell receptor (TCR) V beta transcripts in livers of primary biliary cirrhosis: preferential V beta usage suggests antigen-driven selection. Clin Exp Immunol 103:99-104, 1996.
58. Kotzin BL, Karuturi S, Chou YK, et al: Preferential T-cell receptor b-chain variable gene use in myelin basic protein-reactive T cell clones from patients with multiple sclerosis. Proc Acad Sci USA 88:9161-5, 1991.
59. Urban KL, Kumar V, Kono DH, et al: Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577-92, 1988.
60. Lehmann PV, Sercarz EE, Forsthuber T, et al: Determinant spreading and the dynamics of the autoimmune T-cell repertoire [see comments]. Immunol Today 14:203-8, 1993.